B-type natriuretic peptide levels in patients with COPD and normal right ventricular function

Advances in Therapy

Volumn 25, Issue 7, 2008, Pages 674-680

  Gemici, Gökmen ^a   Erdim, Refik ^b   Celiker, Aydin ^c   Tokay, Sena ^c   Ones, Tunc ^c   Inanir, Sabahat ^c   Oktay, Ahmet ^c  

^a NAMIK KEMAL UNIVERSITY   (Turkey)

^b FLORENCE NIGHTINGALE HOSPITAL   (Turkey)

^c MARMARA UNIVERSITY   (Turkey)

Author keywords

Brain natriuretic peptide; Chronic obstructive pulmonary disease; Right ventricle

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; BIOSYNTHESIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; EXERCISE TEST; FEMALE; HEART RIGHT VENTRICLE FUNCTION; HUMAN; LUNG FUNCTION TEST; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; VENTRICULAR FUNCTION, RIGHT;

EID: 58149352847     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-008-0067-1     Document Type: Article

References (25)

1. Klinger JR, Hill NS. Right ventricular dysfunction in chronic obstructive pulmonary disease. Chest. 1991;99:715-723.
2. Ranzetti AD Jr, McClement JH, Litt BD. The Veterans Administration cooperative study of pulmonary function. Mortality in relation to respiratory function in chronic obstructive pulmonary disease. Am J Med. 1966;41:115-129.
3. Mitchell RS, Webb NC, Filley GF. Chronic obstructive pulmonary disease III. Factors infuencing prognosis. Am Rev Respir Dis. 1964;89:878-896.
4. Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. A 15 year follow-up study. Am Rev Respir Dis. 1979;119:895-902. (Pubitemid 9208242)
5. Weitzenblum E, Loiseau A, Hirth C, Mirhom R, Rasaholinjanahary J. Course of pulmonary hemodynamics in patients with chronic obstructive pulmonary disease. Chest. 1979;75:656-662. (Pubitemid 9221240)
6. Boushy SF, North LB. Hemodynamic changes in chronic obstructive pulmonary disease. Chest. 1977;72:565-570. (Pubitemid 8228788)
7. Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Pelletier A. Long term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1985;131:493-498. (Pubitemid 15086729)
8. Timms RM, Khaja FU, Williams GW. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med. 1985;102:29-36. (Pubitemid 15187651)
9. Zielinski J, Tobiasz M, Hawrylkiewicz I, Sliwinski P, Palasiewicz G. Effects of long term oxygen therapy on pulmonary hemodynamics in COPD patients. A 6-year prospective study. Chest. 1998;113:65-70. (Pubitemid 28044926)
10. Fujimoto K, Matsuzawa Y, Yamaguchi S, Koizumi T, Kubo K. Benefts of oxygen on exercise performance and pulmonary hemodynamics in patients with COPD with mild hypoxemia. Chest. 2002;122:457-463. (Pubitemid 35002121)
11. Kessler R, Faller M, Weitzenblum E, et al. Natural history of pulmonary hypertension in a series of 131 patients with chronic obstructive lung diseases. Am J Respir Crit Care Med. 2001;164:219-224. (Pubitemid 34001285)
12. Nagaya N, Nishikimi T, Okano Y, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol. 1998;31:202-208. (Pubitemid 28064743)
13. Tulevski II, Groenink M, van der Wall EE, et al. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction. Heart. 2001;86:27-30. (Pubitemid 32977776)
14. Ando T, Ogawa K, Yamaki K, Hara M, Takagi K. Plasma concentrations of atrial, brain and C-type natriuretic peptides and endothelin-1 in patients with chronic respiratory disease. Chest. 1996;110:462-468. (Pubitemid 26269279)
15. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. GOLD Scientifc Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163:1256-1276. (Pubitemid 32378468)
16. Manno BV, Iskandrian AS, Hakki AH. Right ventricular function: methodologic and clinical considerations in noninvasive scintigraphic assessment. J Am Coll Cardiol. 1984;3:1072-1081. (Pubitemid 14171225)
17. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to update the 1997 exercise testing guidelines). Circulation. 2002;106:1883-1892.
18. Moe GW. B-type natriuretic peptide in heart failure. Curr Opin Cardiol. 2006;21:208-214. (Pubitemid 44315085)
19. Leuchte HH, Baumgartner RA, Nounou ME, et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med. 2006;173:744-750.
20. Burke MA, Cotts WG. Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions. Heart Fail Rev. 2007;12:23-36. (Pubitemid 46629244)
21. Leuchte HH, Holzapfel M, Baumgartner RA, et al. Clinical signifcance of brain natriuretic peptide in primary pulmonary hypertension. J Am Coll Cardiol. 2004;43:764-770. (Pubitemid 38296473)
22. Schulman DS, Matthay RA. The right ventricle in pulmonary disease. Clin Cardiol. 1992;10:111-135.
23. Brent BN, Mahler D, Matthay RA, Berger HJ, Zaret BL. Noninvasive diagnosis of pulmonary arterial hypertension in chronic obstructive pulmonary disease: right ventricular ejection fraction at rest. Am J Cardiol. 1984;53:1349-1353. (Pubitemid 14118880)
24. Crockett AJ, Cranston JM, Moss JR, Alpers JH. Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005;(4):CD001744.
25. Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefts of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med. 2003;168:1034-1042. (Pubitemid 37338931)